✦ LIBER ✦

Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency

✍ Scribed by B. JENABALI JAHROMI; M. KARIMI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Congenital factor VII deficiency: therap

✍ G. MARIANI; B. A. KONKLE; J. INGERSLEV 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Recombinant factor VIIa prophylaxis in a

✍ W. Y. Tcheng; J. Donkin; S. Konzal; W.-Y. Wong 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Prophylactic effect of recombinant facto

✍ M. KARIMI; R. SHAFIEIAN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

The use of recombinant activated factor

✍ Weei-Yuarn Huang; Margot S. Kruskall; Kenneth A. Bauer; Lynne Uhl; Beth H. Shaz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Successful prophylaxis against intracran

✍ R. A. FARAH; D. HAMOD; N. MELICK; M. GIANSILY-BLAIZOT; S. SALLAH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

What dose of recombinant activated facto

✍ S. A. Brown 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB